UPDATE 1-COVID-19 vaccine makers start work on Omicron-tailored shots




 

(Adds details from BioNTech, J&J statements) 

  Nov 29 (Reuters) - BioNTech, Moderna and Johnson & Johnson are working on vaccines that specifically target Omicron in case their existing shots are not effective against the new coronavirus variant, the companies said on Monday. 

  The variant's emergence has triggered a strong global response as countries worried that it could spread fast even in vaccinated populations impose travel curbs and other restrictions. 

  BioNTech SE said it had started work on a vaccine tailored to Omicron, along with partner Pfizer. 

  Meanwhile, Moderna Inc said it could take months to begin shipping such a vaccine, Chief Executive Officer Stéphane Bancel told CNBC. 

  Bancel said the effectiveness of existing COVID-19 vaccines against the variant was currently not known, adding there should be more clarity in about two weeks. 

  Johnson & Johnson is also evaluating the effectiveness of its COVID-19 vaccine against Omicron, while also pursuing a vaccine specific to the variant. 

  "We have begun work to design and develop a new vaccine against Omicron and will rapidly progress it into clinical studies if needed," said Mathai Mammen, global head of research for J&J's pharmaceuticals unit. 

  A top South African infectious disease expert said Omicron appears to be more transmissible than previous variants, including to people with immunity from vaccination or prior infection. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila) 

COMMENTS

More Related News

Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron
Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron
  • US
  • 2022-01-17 16:23:40Z

JERUSALEM (Reuters) -A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron...

Moderna CEO says data for Omicron-specific shot likely available in March
Moderna CEO says data for Omicron-specific shot likely available in March
  • US
  • 2022-01-17 14:05:46Z

Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot. Bancel said the best case scenario...

Analysis-China
Analysis-China's 'zero-COVID' campaign under strain as Omicron surges
  • US
  • 2022-01-17 13:21:28Z

China is doubling down on its "zero-COVID" strategy, saying the spread of the potentially milder Omicron variant is no reason to lower its guard amid...

Omicron Reaches China
Omicron Reaches China's Political, Financial and Tech Hubs

(Bloomberg) -- Omicron has breached the political, financial and technology centers of China for the first time, putting pressure on the country's response...

'I have no intention of getting infected': understanding Omicron's severity

Experts on whether getting Covid is inevitable and why, despite claims of 'mildness', the variant is highly dangerous 'Omicron's breaking the backs of the...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Economy